Cancer Society Updates Prostate Screening Guidelines

The American Cancer Society (ACS) has updated its guidelines for prostate cancer screening, recommending PSA tests every two years for average-risk men ages 50 to 69. This is the organization’s first update on the topic since 2010.
The new guideline, published in CA: A Cancer Journal for Clinicians, also advises earlier testing for Black men, who should start annual screening at 45. According to the ACS, Black men have a 67% higher incidence and nearly double the mortality rate of White men.
Screening Recommendations
ACS chief scientific officer William Dahut says the new advice is based on long-term data from studies done mainly in Europe, where men screened every two years had lower prostate cancer mortality. Men between 70 and 74 are advised to make an individual decision about screening, while it is not recommended for men 75 and older, except in certain cases.
More than 330,000 people will be diagnosed with prostate cancer in the United States this year, according to Yaw Nyame, a physician at the Fred Hutchinson Cancer Center. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime.
The USPSTF, a federal task force, still recommends that the decision to undergo PSA screening be made on an individual basis for men 55 to 69, giving it a C grade. This reflects a long-running debate about the benefits and drawbacks of routine screening.
Debate Over Screening
Some experts, including Andrew Wolf, who chaired the ACS guideline development group, argue that the benefits of screening now outweigh the downsides. However, others point to the risk of overdiagnosis, which can lead to unnecessary biopsies and treatment.
Read Also: AI demands powerful and efficient hardware
A Cochrane review published in May 2026 found that PSA screening likely reduces prostate cancer deaths by about two per 1,000 men screened. The UK National Screening Committee has also recommended targeted screening for men aged 45 to 61 who have a BRCA2 gene change and a family history of certain cancers.
What Happens When PSA Results Come Back High?
The new ACS guideline includes a pathway for men with raised PSA results. An raised result should be repeated within two weeks to three months. If it stays high, most men are offered an MRI, a validated blood biomarker test, or both before any biopsy. A PSA of 3 ng/mL or higher in men under 70 triggers a repeat test; for men 70 and older, the threshold is 6.5 ng/mL. Men diagnosed with low-risk cancer should be offered active surveillance as the first approach, which involves close monitoring with regular PSA tests, biopsies, and sometimes MRIs, with treatment if the cancer shows signs of becoming higher risk.
As the debate over screening continues, men are advised to discuss their individual risk factors and screening options with their clinicians. The ACS recommends that men 50 to 69 who decide to undergo PSA screening should bring both the ACS and USPSTF recommendations to their appointment and ask about follow-up procedures.
Reducing Unnecessary Biopsies
The Cochrane authors noted it is too soon to know whether newer approaches that pair PSA with a biomarker panel and MRI save more lives or cause fewer harms than PSA testing alone.
Movember’s Campaign
Google’s Mustache Protocol game donates $11 to Movember for each play through November 30, up to $500,000. Participants start clean-shaven on November 1 and grow a mustache through the month. Those who skip the mustache can walk or run 60 km (37 miles) over November, host an event, or set their own challenge. The campaign runs through November 30.
